Tony Oosterveen is a Principal Scientist at bit.bio a company pioneering the generation of physiologically relevant human cell types from induced pluripotent stem cells (iPSCs) with its deterministic, cell programming opti-ox technology. Tony leads a team focused on developing different neuronal subtypes and glial cells. 

Tony discusses how using their opti-ox technology, they developed a potential pain model that could help develop more effective drugs for pain.